The Two Questions Every Founder Asks After the Report

Every VentureReady evaluation ends the same way for the founder reading it. The report lays out what's strong, what's weak, and what's missing — slide by slide, red flags ranked by severity. And then, almost every time, we get one of two replies:

"OK — so what do I do now?"

"OK — so who do I actually pitch?"

Fair questions. A diagnosis isn't a plan, and a fixed deck isn't a target list. So we built a report for each one.

---

The Growth Roadmap: what to do now

If your evaluation surfaced real gaps — no customer discovery, a capital ask that doesn't match your scope, a missing go-to-market story — the Growth Roadmap turns those findings into a 90-day plan.

Not advice. A plan. It includes customer discovery scripts you can use this week and a week-by-week schedule that ends with a signed letter of intent. A beachhead go-to-market sequence — which customers first, which channels, what to defer. Product improvements ordered by what has to exist before your pilot, during it, and after your round. And a milestone map that connects all of it to the investor conversation you're working toward.

It's built directly from your evaluation's priority findings, so it addresses your actual gaps — not generic startup homework.

$147, delivered within 48 hours of purchase.

The Fund Match: who to pitch

This one we're especially proud of. We maintain a database of emerging VC funds — mostly Fund I and Fund II managers who closed new vehicles within the last 12 to 18 months. That detail matters more than most founders realize: a fund that just closed is actively writing first checks, and an emerging manager reads cold inbound in a way a name-brand firm simply doesn't. We refresh the database on a monthly cycle and verify every fund against public sources.

The Fund Match runs your company against that database and delivers the six funds whose published investment thesis best fits you — with the reasoning spelled out for each one. Check sizes. Whether they lead rounds or follow. A recommended order to approach them in. Even the near misses: funds that almost fit, and what would have to change for them to say yes.

One thing the Fund Match is not: an introduction service. We have no relationship with the funds we match, and we don't take a percentage of anything. It's research — the same research you'd spend weeks doing yourself, done rigorously and verified before it reaches you.

$127, delivered within 48 hours of purchase.

Why both require the evaluation

You can't buy either report on its own, and that's deliberate.

The Roadmap is built from your evaluation's findings — without them, it's a generic checklist. The Fund Match depends on knowing your real stage, sector, round size, and traction — without a diagnosis, it's guesswork with confident formatting. Plenty of services will sell you an investor list without asking a single hard question about your business first. We think that's exactly backwards.

So the sequence is: evaluation first ($97, same as always). Your report arrives within 24 hours, and the offer for both add-ons arrives with it. Take one, both, or neither — the evaluation stands on its own either way.

Diagnose. Fix. Target. In that order.

---

Ready to start? Get your evaluation — the two questions can wait 24 hours.